Prediction of dissolution-absorption relationships from a continuous dissolution/caco-2 system

AAPS PharmSci

Volumn 1, Issue 2, 1999, Pages 27-38

  Ginski, Mark J ^a   Taneja, Rajneesh ^a   Polli, James E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; METOPROLOL; PIROXICAM; RANITIDINE;

ABSORPTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COMPARATIVE STUDY; HUMAN; METABOLISM; SOLUBILITY;

ABSORPTION; CACO-2 CELLS; CARBOXYMETHYLCELLULOSE; CELL MEMBRANE PERMEABILITY; COMPARATIVE STUDY; HUMAN; METOPROLOL; PIROXICAM; RANITIDINE; SOLUBILITY;

EID: 33947276437     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: 10.1208/ps010203     Document Type: Article

References (24)

1. Ginski MJ, Polli JE. Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system. Int J Pharm. 1998;177:117-125.
2. Piscitelli DA, Bigora S, Propst C, et al. The impact of formulation and process changes in vitro dissolution and the bioequivalence of piroxicam capsules. Pharm Dev Technol. 1998;3:443-452.
3. Rekhi GS, Eddington NE, Fossler MJ, Schwartz P, Lesko LJ, Augsburger LL. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Pharm Dev Technol. 1997;2:11-24.
4. Goskonda S, Propst C, Augsburger LL, Schwartz P, Lesko LJ. Investigating the influence of formulation and process variables on the performance of ranitidine HCl tablets. Pharm Res. 1994;11:S-163.
5. Piscitelli DA, McGlone Dalby J, Augsburger LL, Shah VP, Lesko LJ, Young D. The effect of formulation (FM), process (P) and batch size (BS) on the oral bioavailability of ranitidine (R) tablets. Pharm Res. 1995;12:S-417.
6. United States Pharmacopeia XXIII. Rockville, MD: US Pharmacopeial Convention, 1994.
7. Dressman JB, Amidon GE, Fleisher D. Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci. 1985; 74:588-589.
8. Polli JE, Crison JR, Amidon GL. Novel approach to the analysis of in vitro-in vivo relationships. J Pharm Sci. 1996;85:753-760.
9. Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997;86:690-700.
10. Polli JE, Ginski MJ. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities. Pharm Res. 1998;15:48-53.
11. Lennernas H, Palm K, Fagerholm U, Artursson P. Comparison between active and passive flux transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int J Pharm. 1996;127:103-107.
12. Lennernas H. Human intestinal permeability. J Pharm Sci. 1998;87:403-410.
13. Takamatsu N, Welage LS, Idkaidak NM, et al. Human intestinal permeability of piroxicam, propanolol, phenylalanine, and PEG 400 determined by jejunal perfusion. Pharm Res. 1997;14:1127-1132.
14. Can LS, Hsyu PH, Pritchard JE, Thakker D. Mechanism of intestinal absorption of ranitidine and ondansetron transport across Caco-2 cell monolayers. Pharm Res. 1993:10:1722-1725.
15. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 1995;269:G467-G475.
16. Denker BM, Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol. 1998;274:F1-F9.
17. Hollenbeck RG, Mitrevej KT, Fan AC. Estimation of the extent of drug-excipient interactions involving croscarmellose sodium. J Pharm Sci. 1983;72:325-327.
18. Hollenbeck RG. Bioavailability of phenylpropanolamine HCl from tablet dosage forms containing croscarmellose sodium. Int J Pharm. 1988;47:89-93.
19. Newton JM, Razzo FN. The influence of additives on the presentation of a drug in hard gelatin capsules. J Pharm Pharmacol. 1977;29:294-297.
20. Corrigan OI, Stanley CT. Dissolution properties of phenobarbitone-β-cyclodextrin systems. Pharm Acta Helv. 1981;56:204-208.
21. El-Arini SK, Leuenberger H. Dissolution properties of praziquantel-β-cyclodextrin systems. Pharm Dev Tech. 1996;1:307-315.
22. Anderberg EK, Arturrson P. Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J Pharm Sci. 1993;82:392-398.
23. Hovgaard L, Brondstad H. Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm Res. 1995;12:1328-1332.
24. Marttin E, Verhoef JC, Merkus FW. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target. 1998;6:17-36.